GGrantIndex
← Search

Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core

$11,116,941N01FY2024AINIH

Duke University, Durham NC

Investigators

Abstract

To provide expertise and state-of-the-art approaches to manufacture, formulate, optimize, and evaluate the safety and toxicity of innovative, cutting-edge influenza vaccine platforms and approaches.

View original record on NIH RePORTER →